Comment on the National Institute for Clinical Excellence technology appraisal Guidance on the use of docetaxel, paclitaxel, gemcitabine and vinorelbine for the treatment of non-small cell lung cancer /
Health Technology Board for Scotland.
National Institute for Clinical Excellence (Great Britain).Guidance on the use of docetaxel, paclitaxel, gemcitabine and vinorelbine for the treatment of non-small cell lung cancer.
Glasgow : Health Technology Board for Scotland,
2001.
Cover title.
Includes bibliographical references.
Antineoplastic agents.
Lungs